@article{article, title  = {{Laboratory Parameters in Adolescent Patients Aged 12–17 with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial}},

 publisher = {{National Society for Cutaneous Medicine}},

 url = {{http://dx.doi.org/10.25251/skin.8.supp.323 }},

 year = {{2024}},

 month = {{1}},

 author = {{Paller A and Cork M and Hong C-H and Soong W and Schneider S and Lo H and Pedersen LRM and Vacko E and Wollenberg A}},

 doi = {{10.25251/skin.8.supp.323}},

 volume = {{8}},

 journal = {{SKIN The Journal of Cutaneous Medicine}},

 issue = {{1}},

 pages = {{s323-s323}},

 note = {{Accessed on 2024/12/22}}}